ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

BRNA Blackrock North American Income Trust Plc

183.50
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Blackrock North American Income Trust Plc LSE:BRNA London Ordinary Share GB00B7W0XJ61 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 183.50 181.00 183.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

BLACKROCK NORTH AMERICAN INCOME TRUST PLC - Portfolio Update

19/01/2017 3:19pm

PR Newswire (US)


Blackrock North American... (LSE:BRNA)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Blackrock North American... Charts.
BLACKROCK NORTH AMERICAN INCOME TRUST plc
All information is at 31 December 2016 and unaudited.
Performance at month end with net income reinvested

   


 
One
Month
Three
Months
Six
Months
One
Year
Three
Years
Since
Launch
(24 Oct 2012)
Net asset value 3.3% 13.8% 19.6% 38.2% 65.9% 98.1%
Share price 7.4% 17.4% 31.5% 53.3% 68.4% 95.8%
Russell 1000 Value Index 3.6% 12.1% 19.4% 40.0% 71.6% 123.5%
Source: BlackRock

   

At month end
Net asset value – capital only:   168.15p
Net asset value – cum income:                                 169.32p
Share price:                                                  169.50p
Premium to cum income NAV:  0.1%
Net yield*:                                                      2.8%
Total assets including current year revenue:                  £116.7m
Gearing:                                                          Nil
Options overwrite:                              17.58%
Ordinary shares in issue**: 68,949,044
Ongoing charges***: 1.04%

   

* Based on dividends of 1.20p per share declared on 3 November, 3 August and 4 May 2016 and 1.10p per share declared on 18 February 2016.
** Excluding 31,412,261 ordinary shares held in treasury.
*** Ongoing charges represent the management fee and all other operating expenses excluding interest as a % of average shareholders’ funds for the year ended 31 October 2016.

   

Benchmark
Sector Analysis Total Assets (%)
Financials 27.8
Health Care 14.2
Energy 11.5
Industrials 10.2
Information Technology 9.4
Consumer Staples 6.9
Consumer Discretionary 5.4
Utilities 5.3
Materials 3.4
Telecommunication Services 2.2
Net current assets 3.7
-----
100.0
=====

   

Country Analysis Total Assets (%)
USA 88.6
United Kingdom 2.3
France 2.0
Canada 1.7
Netherlands 0.8
Ireland 0.5
China 0.4
Net current assets 3.7
-----
     100.0  
=====

   

Ten Largest Investments
Company Country of Risk Total Assets (%)
Bank of America USA 4.3
JPMorgan Chase USA 3.9
Pfizer USA 3.4
Wells Fargo USA 2.9
Citigroup USA 2.8
General Electric USA 2.6
Microsoft USA 2.2
Oracle USA 2.0
Merck USA 2.0
Occidental Petroleum USA 1.8

   

Bob Shearer and Tony DeSpirito, representing the Investment Manager, noted:
Performance
For the one month period ended 31 December 2016, the Company’s NAV increased by 3.3% whilst the share price rose by 7.4% (all in sterling). The Company’s benchmark, the Russell 1000 Value Index, gained 3.6% for the period. 

The largest contributor to relative performance during the month was stock selection in the energy sector.  Notably, our position in non-benchmark holding Total (+9.6% in GBP) and our overweight to Hess Corporation (+11.0% in GBP) proved to be beneficial.  Stock selection in consumer staples also added to relative returns as our decision to own non-benchmark holding Kroger and to not own benchmark holding Wal-Mart Stores, contributed positively.  Lastly, stock selection in the financials and materials sectors also added modestly to relative performance.

The largest detractor from relative performance was stock selection in the aerospace & defence industry. Notably, our positions in non-benchmark holdings Northrop Grumman (-5.5% in GBP) and Lockheed Martin (-4.7% in GBP) proved to be costly.  Stock selection in telecommunication services also dampened relative returns, as did our underweight to the real estate sector.  Lastly, an overweight to the health care providers & services industry hurt relative performance during the month.

Transactions/Options
Transactions: Notable portfolio changes included increasing our allocation to the technology sector through adding to positions in Intel and Oracle. In materials, we reduced our allocation to E.I. du Pont de Nemours and Company and used the proceeds to increase our position in Dow Chemical Company.  Lastly, we trimmed our exposure to existing positions in Bank of America, General Electric and Raytheon.

Options:  As at 31 December 2016, the Company’s options exposure was 17.58% and the delta of the options was 87.92%. 

Positioning
The Company is currently overweight to the health care, consumer discretionary, financials and materials sectors.  We are approximately equal-weight in the industrials and information technology sectors, and underweight to real estate, telecommunications, energy, utilities, and consumer staples.
19 January 2017

Copyright y 19 PR Newswire

1 Year Blackrock North American... Chart

1 Year Blackrock North American... Chart

1 Month Blackrock North American... Chart

1 Month Blackrock North American... Chart

Your Recent History

Delayed Upgrade Clock